Stay updated on Sage-217 Efficacy in MDD Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.

Latest updates to the Sage-217 Efficacy in MDD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedThe government funding status notice banner was removed, and this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check44 days agoChange DetectedBiogen is now listed as the sponsor following a transfer from Sage Therapeutics, and the study results were posted (Results First Posted 2023-12-05).SummaryDifference0.3%

- Check73 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check80 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.3%

- Check94 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Sage-217 Efficacy in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.